IN2013MU03641A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03641A IN2013MU03641A IN3641MU2013A IN2013MU03641A IN 2013MU03641 A IN2013MU03641 A IN 2013MU03641A IN 3641MU2013 A IN3641MU2013 A IN 3641MU2013A IN 2013MU03641 A IN2013MU03641 A IN 2013MU03641A
- Authority
- IN
- India
- Prior art keywords
- amorphous form
- idelalisib
- relates
- abstract
- processes
- Prior art date
Links
- YKLIKGKUANLGSB-HNNXBMFYSA-N idelalisib Chemical compound C1([C@@H](NC=2[C]3N=CN=C3N=CN=2)CC)=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1 YKLIKGKUANLGSB-HNNXBMFYSA-N 0.000 abstract 3
- 229960003445 idelalisib Drugs 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3641MU2013 IN2013MU03641A (enrdf_load_stackoverflow) | 2013-11-20 | 2014-11-19 | |
| PCT/IN2014/000724 WO2015092810A2 (en) | 2013-11-20 | 2014-11-19 | Amorphous form of idelalisib |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3641MU2013 IN2013MU03641A (enrdf_load_stackoverflow) | 2013-11-20 | 2014-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03641A true IN2013MU03641A (enrdf_load_stackoverflow) | 2015-07-31 |
Family
ID=52785145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3641MU2013 IN2013MU03641A (enrdf_load_stackoverflow) | 2013-11-20 | 2014-11-19 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03641A (enrdf_load_stackoverflow) |
| WO (1) | WO2015092810A2 (enrdf_load_stackoverflow) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016097314A1 (en) * | 2014-12-19 | 2016-06-23 | Sandoz Ag | Amorphous and crystalline forms of idelalisib and process for forming the same |
| WO2016147206A1 (en) | 2015-03-13 | 2016-09-22 | Mylan Laboratories Limited | Process for the preparation of amorphous idelalisib and its premix |
| WO2016157136A1 (en) | 2015-04-02 | 2016-10-06 | Mylan Laboratories Ltd | Crystalline forms of idelalisib |
| CN108033961A (zh) * | 2015-04-15 | 2018-05-15 | 上海方楠生物科技有限公司 | 一种艾德力布的无定型物及其制备方法 |
| WO2017137097A1 (en) * | 2016-02-12 | 2017-08-17 | Synthon B.V. | Pharmaceutical composition comprising idelalisib in amorphous form |
| WO2017175184A1 (en) * | 2016-04-07 | 2017-10-12 | Laurus Labs Limited | Process for preparation of amorphous form of idelalisib |
| EP3272348A1 (en) | 2016-07-21 | 2018-01-24 | LEK Pharmaceuticals d.d. | Pharmaceutical composition comprising idelalisib |
| WO2019178596A1 (en) | 2018-03-16 | 2019-09-19 | Johnson Matthey Public Limited Company | Pyridine or n,n-dimethyl acetamide solvated solid state forms of solvated idelalisib, their use and preparation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2607804T3 (es) | 2004-05-13 | 2017-04-04 | Icos Corporation | Quinazolinones como inhibidores de la fosfatidilinositol humana 3-quinasa delta |
| BR112014021935A2 (pt) | 2012-03-05 | 2019-09-24 | Gilead Calistoga Llc | formas polimórficas de (s)-2(l-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenilquinazolina-4(3h)ona |
-
2014
- 2014-11-19 IN IN3641MU2013 patent/IN2013MU03641A/en unknown
- 2014-11-19 WO PCT/IN2014/000724 patent/WO2015092810A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015092810A3 (en) | 2015-08-13 |
| WO2015092810A2 (en) | 2015-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501710A1 (en) | Combination formulation of two antiviral compounds | |
| MX2020005181A (es) | Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam). | |
| IN2015DN00127A (enrdf_load_stackoverflow) | ||
| MX2021011906A (es) | Composiciones de liberacion retardada de linaclotida. | |
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| IN2013MU03641A (enrdf_load_stackoverflow) | ||
| IN2013MU00646A (enrdf_load_stackoverflow) | ||
| MX2014005510A (es) | Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas. | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| IN2013MU00848A (enrdf_load_stackoverflow) | ||
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| IL243435B (en) | Pharmaceutical preparations of pancreatin with high potency | |
| IN2013MU03918A (enrdf_load_stackoverflow) | ||
| SG10201900598TA (en) | Factor viii formulation | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| IN2014CH00840A (enrdf_load_stackoverflow) | ||
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| IN2013MU01113A (enrdf_load_stackoverflow) | ||
| EP3063152A4 (en) | Convenient preparation of n-substituted morphinan-6-ols from morphinan-6-ones | |
| NZ721832A (en) | Solid forms of tenofovir | |
| EP3016981A4 (en) | Compositions and methods for treatment of stroke | |
| IN2013MU03317A (enrdf_load_stackoverflow) | ||
| IN2013MU02528A (enrdf_load_stackoverflow) | ||
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin |